未登录

K

Kinga Viktória Kőhalmi

Semmelweis University

H指数:13

被引数:527

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A national survey of four decades of hereditary angioedema prophylaxis: Efficacy and safety of old and new drugs

一项关于四十年遗传性血管性水肿预防的全国性调查：老药和新药的有效性与安全性

clinical immunology

IF3.8

2025-06-110

OA

Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry

用于遗传性血管性水肿发作的重组人C1酯酶抑制剂: 欧洲注册表

WORLD ALLERGY ORGANIZATION JOURNAL

IF4.3

2021-04-017

OAAI

How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

IF11.3

2021-03-0313

OAAI

Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

IF11.3

2021-02-197

OAAI

The Importance of Complement Testing in Acquired Angioedema Related to Angiotensin-Converting Enzyme Inhibitors

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2021-02-0116

OAAI

A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency

JOURNAL OF INTERNAL MEDICINE

IF9.2

2020-11-2016

PREAI

Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2020-07-0110

OAAI

Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients

健康人和遗传性血管性水肿患者的C1-Inhibitor/血浆丝氨酸蛋白酶复合物的模式

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-05-0535

OAAI

Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-04-019

OAAI

Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-03-014

OAAI

Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2018-07-0111

PREAI

Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years

EXPERT REVIEW OF CLINICAL IMMUNOLOGY

IF3.7

2018-05-2417

PREAI

Real-life experience with recombinant human C1-inhibitor in treatment of hereditary angioedema with C1-inhibitor deficiency

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2018-02-010

PREAI

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema

EXPERT OPINION ON INVESTIGATIONAL DRUGS

IF4.1

2017-12-158

PREAI

Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack

IF12

2017-10-306

PREAI

A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum

IMMUNOLOGY LETTERS

IF2.8

2017-09-0111

PREAI

The relationship between anxiety and quality of life in children with hereditary angioedema

PEDIATRIC ALLERGY AND IMMUNOLOGY

IF4.5

2017-08-1132

PREAI

Health-related quality of life among children with hereditary angioedema

PEDIATRIC ALLERGY AND IMMUNOLOGY

IF4.5

2017-04-0441

PREAI

Safety Of Plasma-derived C1-inhibitor Treatment In Pediatric Patients With Hereditary Angioedema Due To C1-inhibitor Deficiency - A Long-term Survey

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2017-02-011

OAAI

Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2017-01-106

OAAI